Trials / Completed
CompletedNCT04365595
SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir)
Recovery in Patients With SARS-CoV-2 Associated Respiratory Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the current pandemic of coronavirus disease (COVID-19) that can lead to respiratory failure requiring oxygen therapy. Some patients develop acute respiratory distress syndrome (ARDS) and may die despite intensive care therapy. Currently it is unknown a) how fast patients recover after being discharged from hospital and b) what underlying predictors may influence recovery.
Detailed description
Study aims: * To evaluate subjective and objective recovery after discharge from hospital in patients with respiratory failure due to COVID-19. * To identify risk factors for COVID-19 associated respiratory failure and prolonged recovery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires, spirometry | Questionnaires targeting health-related quality-of-life, symptoms, anxiety and depression |
Timeline
- Start date
- 2020-06-03
- Primary completion
- 2021-02-17
- Completion
- 2021-02-17
- First posted
- 2020-04-28
- Last updated
- 2021-02-23
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04365595. Inclusion in this directory is not an endorsement.